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Abstract 
We reported previously that the prevalence of drug-resistant HIV-1 among 
antiretroviral treatment (ART)-naive individuals in Northern Vietnam was 2.9% in 
2007 and 6.2% in 2008. To investigate the continuing trend of prevalence, we collected 
plasma samples from 958 individuals in Hai Phong and Hanoi in 2009, extracted viral 
RNA from HIV-1 antibody-positive samples, and analyzed them genetically. 
HIV-1-antibody prevalence was 26.8% in injecting drug users (n =302), 13.4% in 
female sex workers (n=284), 0.5% in blood donors (n =206), and 0.6% in pregnant 
women (n =166). All HIV-1 strains were CRF01_AE. Non-nucleoside 
reverse-transcriptase inhibitor-resistance mutations were found in two (2.0%) of the 
102 successfully analyzed cases (one case with the Y181C, and one with the K101E). 
No nucleoside reverse-transcriptase inhibitor-resistance or protease inhibitor-resistance 
mutations were detected. The prevalence of circulating ART-resistant HIV-1 in 
Northern Vietnam did not increase from 2007 to 2009, although the rate of ART 
coverage did increase. 
 
 In Vietnam, the first human immunodeficiency virus type 1 (HIV-1)-infected 
case was reported in Ho Chi Minh City in 1990,1 and HIV-1 infection had spread 
throughout the entire country by 1999.2 In 2010, an estimated 254,000 people in 
Vietnam were living with HIV.3 The most prevalent HIV-1 subtype in Vietnam is 
CRF01_AE, though subtype B, subtype C, and intersubtype recombinants have also 
been identified.4-9 Antiretroviral therapy (ART) has been introduced to Vietnam 
intensively since 2003. The ART coverage rate among adults increased from 30% in 
2007 to 53.7% in 2009,3 which might induce the appearance and circulation of 
ART-resistant HIV-1 strains in Vietnam. Previously we conducted studies on the 
prevalence of drug-resistant HIV-1 strains among ART-naïve HIV-1infected patients in 
Northern Vietnam, and observed prevalences of 2.9% in Haiphong in 20074 and 6.2% in 
three provinces, including Hanoi, in 2008.5 In the current study, we investigated the 
trend in the prevalence of HIV-1 and drug-resistant HIV-1 in Northern Vietnam between 
2007 and 2009. 
Plasma samples were collected from 958 individuals residing in two cities in 
Northern Vietnam (n=738 from Hai Phong and n=220 from Hanoi) in 2009. The study 
participants were divided into four groups according to their HIV-1-infection risks: 
injecting drug users (n=302), female sex workers (n=284: 64 from Hai Phong and 220 
from Hanoi), blood donors (n=206), and pregnant women (n=166). The characteristics 
of the participants are summarized in Table 1. None had any previous history of ART. 
Plasma samples were screened for anti-HIV antibody (Determine HIV-1/2; Inverness 
medical Japan Co., Ltd., Tokyo, Japan). HIV-1 RNA was extracted from 100 μl of 
anti-HIV-1-positive plasma samples using a SMITEST EX-R&D Nucleic Acid 
Extraction Kit (Genome Science Laboratories, Fukushima, Japan) according to the 
manufacturer’s instructions. The protease- and reverse transcriptase-encoding regions 
of the HIV-1 pol gene (pol-PR and the pol-RT, respectively) were amplified by 
one-step reverse transcription-polymerase chain reaction (RT-PCR; SuperScript III 
One-step RT-PCR System with Platinum Taq High Fidelity; Invitrogen, Carlsbad, CA), 
and then by nested PCR using KOD FX (Tokyo, Osaka, Japan) as described 
previously.4, 5 The amplified PCR products were sequenced directly and/or after 
cloning, if necessary, and analyzed using an ABI Prism 310 Genetic Analyzer (Applied 
Biosystems). The sample nucleotide sequences were aligned with HIV-1-subtype 
reference sequences retrieved from the Los Alamos database, and with previously 
reported sequences of HIV-1 strains isolated from Southeast Asia and Southern China 
using ClustalW (version 1.83) with minor manual adjustments. Phylogenetic trees were 
constructed and visualized as described previously.4, 5 The pol-PR (297 base pairs) and 
pol-RT (660 base pairs) nucleotide sequences were translated into the corresponding 99 
and 220 amino acids, respectively. Using the Stanford University HIVdb sequence 
analysis program and the International AIDS Society-USA November 2011 list,10 we 
analyzed the amino acid sequences for drug resistance-associated mutations. 
Of the 958 individuals, 121 individuals were positive for HIV-1 antibody: 
prevalence was 26.8% (81/302) in injecting drug users, 13.4% (38/284) in female sex 
workers, 0.5% (1/206) in blood donors, and 0.6% (1/166) in pregnant women (Table 1). 
Notably, the HIV-1 prevalence among high-risk groups in Northern Vietnam in 2009 
was significantly lower than reported in our previous study in 20074: 35.9% (n=760) in 
injecting drug users (p=0.006) and 23.1% (n=91) in female sex workers (p=0.041). 
These findings indicate that the HIV-1 epidemic in Northern Vietnam is still in a 
concentrated stage among high-risk groups such as injecting drug users and female sex 
workers, with a gradual decrease of HIV-1 prevalence, as observed in other areas of 
Vietnam.3 These findings also suggest that the Preventing HIV Project in Vietnam, 
which targets injecting drug users and female sex workers, may have taken effect to 
reduce the number of new infections in the main risk groups in Hai Phong.11, 12 
Of the 121 HIV-1 antibody-positive samples, 107 samples were successfully 
analyzed genetically for pol-PR and 102 were successfully analyzed for pol-RT. 
Phylogenetic analysis revealed that all of the isolated strains belonged to HIV-1 
CRF01_AE, and most of them formed a large cluster with previously-reported 
sequences from Northern Vietnam and Southern China, as reported previously4, 6 (data 
not shown). Non-nucleoside reverse-transcriptase inhibitor (NNRTI)-resistance 
mutations were observed in two (2.0%) of the 102 successfully analyzed cases: one 
case with the Y181C mutation, and one with the K101E mutation (Table 2). The 
Y181C and K101E mutations are common drug-resistant mutations observed in 
CRF01_AE-infected individuals who are failing nevirapine-based therapy.13 The 
K101E mutation was first identified among ART-naïve individuals in Vietnam. The 
potential NNRTI-resistance mutations, V106I and V179D, were observed in three 
cases each (2.9%). No nucleoside reverse-transcriptase inhibitor-resistance or major 
protease inhibitor (PI)-resistance mutations were detected; however, the minor 
PI-resistance mutations L10I, L10V, K20I, and A71V, were detected in eleven (10.3%), 
four (3.7%), four (3.7%), and one (0.9%) cases, respectively, as observed previously.4 
The overall prevalences of reverse-transcriptase inhibitor-resistance and PI-resistance 
mutations were 2.0% and 0%, respectively. Therefore, the prevalence of circulating 
ART-resistant HIV-1 in Northern Vietnam slightly decreased from 2.9% in 20074 and 
6.2% in 20085 to 2.0% in 2009 (current study), although the ART coverage rate in 
Vietnam increased from 30% in 2007 to 53.7% in 2009.3 Interestingly, the two cases 
harboring drug-resistant HIV-1 were not injecting drug users from Hai Phong, but 
female sex workers from Hanoi, while in our previous study in Hai Phong4 all 
individuals with drug-resistant HIV-1 were injecting drug users. This finding might be 
due to the successful outcome of the HIV prevention programs in Hai Phong, such as 
harm reduction interventions for injecting drug users, which include distributing clean 
needles and condoms, as well as methadone maintenance therapy.3, 11 This finding also 
suggests that the prevalence of circulating ART-resistant HIV-1 can differ among 
groups and areas, even within Northern Vietnam. These findings indicate that there is 
still a need for the monitoring of drug-resistance mutations in Northern Vietnam. 
The GenBank accession numbers of the sequences reported in this study are as 
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Table 1. Characteristics of the study participants and prevalence of HIV-1 antibody 
  Male/ Mean HIV-1 Antibody Positive (%) 
Groups n Female age (SD) Current study Study in 2007+ 
IDU 302 302/0 32.5 (8.5) 26.8%* 35.9% (n=760)* 
FSW 284 0/284 28.0 (8.2)  13.4%**  23.1% (n= 91)** 
Blood donors 206 182/24 29.1 (8.3) 0.5% 2.9% (n=210) 
Pregnant women 166 0/166 26.1 (5.4) 0.6% 0.5% (n=200) 
Total 958 484/474 29.0 (8.2) n=121  
IDU, injecting drug users; FSW, female sex workers. 
+ Ishizaki A, et al. AIDS Res Hum Retroviruses 2009;25(2):175-183. (Ref. No 4). 
* p=0.006; **p=0.041 
Table 2. Characteristics of Vietnamese individuals harboring antiretroviral 
drug-resistance mutations 
Sample Age/  HIV-1 PI resistance RTI resistance mutations
ID Sex City subtype mutations NRTI NNRTI 
HPV2_124_09 30/F Hanoi CRF01_AE none none K101E 
HPV2_209_09 22/F Hanoi CRF01_AE none none Y181C 
PI, protease inhibitor; RTI, reverse-transcriptase inhibitor; NRTI, nucleoside RTI; 
NNRTI: non-nucleoside RTI. 
 
